# Phase 2a Study for PK/PD of nC-001

> **NCT06798675** · PHASE2 · NOT_YET_RECRUITING · sponsor: **nephCentric** · enrollment: 24 (estimated)

## Conditions studied

- CHRONIC HYPONATREMIA

## Interventions

- **DRUG:** nC-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06798675
- **Lead sponsor:** nephCentric
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2026-03
- **Final completion:** 2026-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798675, "Phase 2a Study for PK/PD of nC-001". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06798675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*